Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2021 Jun 1;105(6):1317-1325.
doi: 10.1097/TP.0000000000003410.

The Introduction of cPRA and Its Impact on Access to Deceased Donor Kidney Transplantation for Highly Sensitized Patients in Australia

Matthew P Sypek  1   2   3   4 , Joshua Y Kausman  3   5   6 , Narelle Watson  7 , Kate Wyburn  8 , Stephen G Holt  1   2 , Peter Hughes  1   2 , Philip A Clayton  4   9   10
Affiliations
Multicenter Study

The Introduction of cPRA and Its Impact on Access to Deceased Donor Kidney Transplantation for Highly Sensitized Patients in Australia

Matthew P Sypek et al. Transplantation. .

Abstract

Background: In March 2016, Australia's deceased donor kidney allocation program introduced calculated panel reactive antibody (cPRA) based on antibody exclusions using multiplex assays to define sensitization for waitlisted candidates. We aimed to assess the impact of this change and review access to transplantation for highly sensitized patients under the current allocation rules.

Methods: Registry data were used to reconstruct changes in panel reactive antibody (PRA)/cPRA for all patients active on the waiting list between 2013 and 2018. A multilevel, mixed-effects negative binomial regression model was used to determine the association between sensitization and transplantation rate in the cPRA era.

Results: Following the introduction of cPRA, there was an increase in the percentage of the waiting list classified as highly sensitized (PRA/cPRA ≥80%) from 7.2% to 27.8% and very highly sensitized (PRA/cPRA ≥99%) from 2.7% to 15.3%. Any degree of sensitization was associated with a decreased rate of transplantation with a marked reduction for those with cPRA 95%-98% (adjusted incidence rate ratio, 0.36 [95% confidence interval, 0.28-0.47], P < 0.001) and cPRA ≥99% (adjusted incidence rate ratio, 0.09 [95% confidence interval, 0.07-0.12], P < 0.001).

Conclusions: The proportion of the waiting list classified as highly sensitized increased substantially following the introduction of cPRA, and despite current prioritization, very highly sensitized patients have markedly reduced access to deceased donor transplantation.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

References

    1. Keith DS, Vranic GM. Approach to the Highly Sensitized Kidney Transplant Candidate. Clin J Am Soc Nephrol. 2016;11:684–693. doi:10.2215/CJN.05930615 - DOI
    1. Sapir-Pichhadze R, Tinckam KJ, Laupacis A, et al. Immune Sensitization and Mortality in Wait-Listed Kidney Transplant Candidates. J Am Soc Nephrol. 2016;27:570–578. doi:10.1681/ASN.2014090894 - DOI
    1. Patel R, Terasaki PI. Significance of the positive crossmatch test in kidney transplantation. N Engl J Med. 1969;280:735–739. doi:10.1056/NEJM196904032801401 - DOI
    1. Gebel HM, Bray RA. HLA antibody detection with solid phase assays : great expectations or expectations too great? Am J Transpl. 2014;14:1964–1975. doi:10.1111/ajt.12807 - DOI
    1. Cecka JM. Calculated PRA (CPRA): the new measure of sensitization for transplant candidates. Am J Transplant. 2010;10:26–29. doi:10.1111/j.1600-6143.2009.02927.x - DOI

Publication types

MeSH terms